Hi MOZZ - 33.5% pa since 2016 is great for sure, My start date in 2018 still very good. I like your confidence going forward, but for me, PAR is now "hold" not "buy" because 2022 is crunch time. Just too many uncertainties. I know pharma very well. They want to acquire technologies, but not the actual small cap company itself if they can avoid it, so I don't worry about us being acquired. Licensing deals generally take at least 6 months & a year is not uncommon. PAR will want max. cash up front in a licensing deal and pharma will want to back load with min. upfront cash so if PR or the new CEO does a deal, the crucial question is how much actual cash will we have in hand by say 4Q '22 to fund the pivotal P3 Zilosul trial in '23-'25?. Trying to get >$60 mil up front cash from pharma by Q4 could be a big ask, but at least if a respectable deal is done with pharma it could lift the SP & make a CR easier. If a deal is not done with pharma in '22, a CR will be very hard yakka in my opinion. Also, any more hiccups and the SP will be on a slippery slope. I suspect the shorters are punting that these uncertainties will keep buyers away until the end of '22. The new CEO needs to deliver a deal with significant cash in the next 12 month IMO or the multi bagger we all hope for is in serious jeopardy. I remain hopeful, but cautious.
PS: IMO Rennie has lost too much credibility which is probably one reason the board encouraged him to step aside. Nearly two years ago he gave us a list of newsflow for the next 12 months including high hopes for a pharma deal. Very little of that has actually been delivered. The new CEO, must tell it like it is; no hype or spin. Whoever he/she is MUST be 1st class and MUST be on board ASAP. This is urgent.
- Forums
- ASX - By Stock
- PAR and the Deal, what do we need?
Hi MOZZ - 33.5% pa since 2016 is great for sure, My start date...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.5¢ |
Change
-0.010(3.92%) |
Mkt cap ! $85.70M |
Open | High | Low | Value | Volume |
24.5¢ | 25.0¢ | 24.0¢ | $59.66K | 241.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 78837 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 36290 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 78837 | 0.245 |
3 | 44840 | 0.240 |
5 | 111000 | 0.235 |
5 | 125200 | 0.230 |
6 | 135884 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.255 | 46689 | 5 |
0.260 | 106349 | 3 |
0.265 | 30000 | 1 |
0.270 | 20000 | 2 |
0.275 | 13636 | 2 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online